This study presents original evidence that SSTR5 expression may be epigenetically regulated by the SSTR5‐AS1 antisense transcript and DNA methylation in pituitary and pancreatic NETs, providing a new regulatory layer influencing receptor levels and, thereby, tumor behavior and treatment response. Here, SSTR5 is linked to neoplasm.